The Analyst Landscape: 7 Takes On TScan Therapeutics
The Analyst Landscape: 7 Takes On TScan Therapeutics
分析师视角：对TScan Therapeutics的7种看法
Analysts' ratings for TScan Therapeutics (NASDAQ:TCRX) over the last quarter vary from bullish to bearish, as provided by 7 analysts.
在过去的季度中，分析师对TScan Therapeutics (NASDAQ:TCRX) 的评级从看好到看淡不一，共有7位分析师提供了评级。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格总结了分析师们最近的评级，揭示了过去30天内情绪的变化并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.43, with a high estimate of $15.00 and a low estimate of $9.00. This upward trend is evident, with the current average reflecting a 0.81% increase from the previous average price target of $12.33.
分析师对12个月的价格目标的评估提供了额外的见解，展示了平均目标为12.43美元，最高的估计值为15.00美元，最低的估计值为9.00美元。这种上升趋势很明显，从先前的平均价格目标12.33美元增加了0.81%。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：更深入的了解
The analysis of recent analyst actions sheds...
对最近分析师行...
登录免费看全文
登录/注册